Description:

CALGB 90601: Treatment Form Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer NCT00942331 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=65402ABE-C4AA-902C-E040-BB89AD435D5A

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=65402ABE-C4AA-902C-E040-BB89AD435D5A

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/8/15
  3. 7/25/15
Uploaded on:

July 25, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Treatment Form Bladder Cancer CALGB 90601 NCT00942331

INSTRUCTIONS: Complete and submit this form as required by the protocol. Information in the upper right box must be completed for this form to be accepted. For optimal accuracy use black ink. Mark an X in the appropriate box for fields with a choice.

Header
Clinical Data
cm
kg
Gemcitabine
Cisplatin
Bevacizumab/placebo
Gemcitabine/Cisplatin